Related Experiment Video
Updated: Feb 22, 2026

04:34
Surgical Treatment of an Endolymphatic Sac Tumor
Published on: May 26, 2023
1.7K
Seronegative Paraneoplastic Limbic Encephalitis Associated with Thymoma.
Jaime Toro1, David Cuellar-Giraldo, Alejandra Duque
1*Department of Neurology, University Hospital of the Fundación Santa Fe de Bogotá †School of Medicine, El Bosque University ‡School of Medicine, University of Los Andes, Bogotá, Colombia.
Summary
Paraneoplastic limbic encephalitis, an autoimmune disorder, can now be diagnosed without antibody tests. Prompt treatment of the associated thymoma improved a patient's neurological symptoms.
Area of Science:
- Neurology
- Immunology
- Oncology
Background:
- Paraneoplastic limbic encephalitis (PLE) is an autoimmune neurological disorder.
- It presents with acute encephalopathy, memory loss, seizures, and behavioral changes.
- Diagnosis traditionally relies on detecting antineuronal antibodies.
Observation:
- A 70-year-old woman presented with acute cognitive decline and choreoathetoid movements.
- MRI revealed temporal lobe abnormalities; CT identified a thymoma.
- The patient met current diagnostic criteria for autoimmune limbic encephalitis.
Findings:
- Treatment with immunotherapy and thymoma resection led to symptom improvement.
- Cerebrospinal fluid antibody tests were negative for PLE.
- This case highlights that PLE diagnosis and treatment can precede antibody confirmation.
Implications:
- Current diagnostic criteria allow for earlier intervention in suspected PLE cases.
- Prompt management of the underlying malignancy is crucial for patient survival and functional recovery.
- Neurologists and psychiatrists must be aware of these updated diagnostic and management approaches for PLE.
More Related Videos
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
3.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.1K
Myasthenia Gravis: Diagnostic Tests
2.8K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.8K

